Pulse Biosciences, Inc.: Pulse Biosciences is a novel bioelectric medicine company bringing to market its proprietary CellFX System platform harnessing its unique Nano-Pulse Stimulation technology. The Company filed for 510(k) clearance with the FDA during 2019 based on strong clinical data from multiple application clinical studies in its first application area, aesthetic dermatology. Clearance is expected during the fourth quarter of 2019 with commercialization following promptly. Commercialization focuses on the deployment of CellFX Systems to clinicians supported and followed by recurring revenues from the CellFX’s networked per use business model. Beyond commercialization, Pulse Biosciences has a rich pipeline of additional applications in dermatology for its existing system, including warts and basal cell carcinoma (BCC) for which clinical studies have already commenced. Additional applications in other fields of medicine are also under investigation.
Healthcare/Medical Devices & Instruments
Based in...
Disease Space
Dermatology, Oncology
Medical Device
Public, USA
Market Cap
100MM - 500MM
849 Mitten Road
Suite 104
Burlingame, CA 94010
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Upcoming Company Event Participation

Solebury Trout Management Access: SF 2020

San Francisco, CA, United States, January 13 – January 16, 2020

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2019 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.